Ephrin type-B receptor 4 couples osteoblastogenesis and osteoclastogenesis, and its expression in MSCs from myeloma patients and in bone cells in myelomatous bones is lower than in healthy counterparts [47]. The gene discussed is EPHB4; the disease is plasma cell myeloma.